Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Dual E-Cigarette and Combustible Tobacco Use Compound Respiratory Disease Risk

Key clinical point: Former and current use of e-cigarettes was independently associated with an increased risk of developing respiratory disease.

Major finding: Former e-cigarette use (adjusted odds ratio, 1.34; 95% confidence interval, 1.23-1.46) and current e-cigarette use (aOR, 1.32; 95% CI, 1.17-1.49) was associated with an increased risk of having incident respiratory disease.

Study details: An analysis of 32,320 adults in the nationally representative, population-based, longitudinal Population Assessment of Tobacco and Health study between September 2013 and October 2016.

Disclosures: This study was supported by grants from the National Institute on Drug Abuse; the National Cancer Institute; the Food and Drug Administration Center for Tobacco Products; the National Heart, Lung, and Blood Institute; and the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center Global Cancer Program. Dr. Bhatta and Dr. Glantz reported no relevant conflicts of interest.


Bhatta DN, Glantz SA. Am J Prev Med. 2019 Dec 16. doi: 10.1016/j.amepre.2019.07.028.